[1]
“Pharmacotherapy Considerations in CKD Patients With COVID-19, A Narrative Review”,
IJKD
, vol. 14, no. 4, pp. 247–255, Jul. 2020, Accessed: Jul. 14, 2025. [Online]. Available:
https://ijkd.org/index.php/ijkd/article/view/5600